Psyence Biomedical (PBM) Consolidated Net Income (2023 - 2025)

Psyence Biomedical (PBM) recorded quarterly Consolidated Net Income of -$1.5 million in Q3 2025, down 230.18% quarter-over-quarter from $1.2 million in Q3 2024, and down 230.18% on a YoY basis from $1.2 million in Q3 2024.

Psyence Biomedical (PBM) Consolidated Net Income (2023 - 2025) Analysis & Trends

Psyence Biomedical's Consolidated Net Income history runs 3 years deep, the most recent figure standing at -$1.5 million for Q3 2025.

  • In Q3 2025, Consolidated Net Income fell 230.18% year-over-year to -$1.5 million; the TTM figure through Sep 2025 stood at -$348875.0 (changed N/A YoY), while the FY2025 annual figure was -$3.7 million, down 232.97% from the prior year.
  • Consolidated Net Income was -$1.5 million for Q3 2025 at Psyence Biomedical, down from $1.2 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $1.2 million in Q3 2024 to a low of -$3.2 million in Q1 2023.
  • Historically, Consolidated Net Income has averaged -$1.2 million across 3 years, with a median of -$1.5 million in 2025.
  • Biggest YoY gain for Consolidated Net Income was 230.18% in 2025; the steepest drop was 230.18% in 2025.
  • A 3-year view of Consolidated Net Income shows it stood at -$3.2 million in 2023, then jumped by 135.74% to $1.2 million in 2024, then sank by 230.18% to -$1.5 million in 2025.
  • The last three Consolidated Net Income figures came in at -$1.5 million (Q3 2025), $1.2 million (Q3 2024), and -$3.2 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -26.94 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.97 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -14.46 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -3.40 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.03 Bn
9 Abivax 94.26 Bn 94.26 Bn - -56.48 Mn
10 Regeneron Pharmaceuticals 66.09 Bn 57.33 Bn 3.31 Bn 727.20 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.50 Mn
Sep 30, 2024 1.16 Mn
Mar 31, 2023 -3.23 Mn